|Obtained degree||Institution||Supervisor / Lab||Focus of work|
|BSc||Jagiellonian University, Kraków||Prof. Alicja Józkowicz||Role of miRNA in myoblast differentiation|
|MSc||University of Göttingen/ Max Planck Institute for Experimental Medicine||Dr. Sandra Goebbels/ Prof. Klaus-Armin Nave||Identification of novel factors troggering oligodendrocytes differentiation|
|PhD||University of Göttingen/ Max Planck Institute for Biophysical Chemistry||Dr. John Chua||Molecular pathways in progression of Alzheimer’s disease|
About Dr. Oleksander Yagensky:
Dr. Oleksandr Yagensky is a consultant at Bain & Company, where he focuses on projects on the intersection of healthcare and private equity industries. He graduated with a PhD from the University of Göttingen (Germany) and the Max Planck Institute for Biophysical Chemistry, where he studied the early markers of Alzheimer’s disease. He previously co-founded Fast Biotechnologies, a medtech start-up developing novel tools to diagnose bacterial infections. Nowadays, in addition to his job as a consultant, he is on the mission to accelerate the progress of personalized medicine by creating a platform in the format of podcasts for all the relevant players in the field to share and discuss their ideas. He will talk about his experiences and motivations throughout his career journey and advise the audience about how to succeed transitioning from academia to consultancy.